Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01883349 · ClinicalTrials.gov registry record
Cognitive Impairment and Imaging Correlates in End Stage Renal Disease
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 120
- Enrollment target
NCT01883349: Completed study, sponsored by University of Kansas Medical Center.
NCT01883349 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01883349 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
This is an observational cohort to understand cognitive impairment in end stage renal disease before and after a kidney transplant.
Primary Outcome
Cognition will be assessed using relevant neuropsychological tests used by National Alzheimers Coordination center (NACC) uniform data set (UDS). Primary outcome will be logical memory. Score range 0-25. Higher scores indicate better cognitive function.
Interventions
- PROCEDURE Kidney Transplant
- OTHER No kidney transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-03 |
| Est. Completion | 2023-09 |
What the finished NCT01883349 record still lists
NCT01883349 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Kidney Transplant is the first listed.
NCT01883349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01883349 about?
NCT01883349 is a clinical study titled "Cognitive Impairment and Imaging Correlates in End Stage Renal Disease". This is an observational cohort to understand cognitive impairment in end stage renal disease before and after a kidney transplant.
What is the current status of trial NCT01883349?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-03. Estimated completion is 2023-09.
What interventions are being tested in trial NCT01883349?
The interventions under investigation include: Kidney Transplant (PROCEDURE), No kidney transplant (OTHER).
Who is sponsoring clinical trial NCT01883349?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia